Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
2018 · Journal of Experimental & Clinical Cancer Research · 77 citations
https://doi.org/10.1186/s13046-018-0718-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
254
Citations
7
h-index
7
i10-index
Qing-Guo Li is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Colorectal Cancer Surgical Treatments & Colorectal and Anal Carcinomas & Cancer Immunotherapy and Biomarkers. The author has an h-index of 7, co-authored 7 publications.
Click to start Chat